Trials that use: Covariate adjustment
5,848 results
- Longitudinal Study of Dental Implant Therapy in HIV Positive Patients: Complete Statistical AnalysisIndependent statistical analysis of Longitudinal Study of Dental Implant Therapy in HIV Positive Patients: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01211288).
- Losartan Potassium/Hydrochlorothiazide 100/25 mg Tablets in Healthy Subjects Under Fasting Conditions: Complete Statistical AnalysisIndependent statistical analysis of Losartan Potassium/Hydrochlorothiazide 100/25 mg Tablets in Healthy Subjects Under Fasting Conditions: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Losartan Potassium/Hydrochlorothiazide 100/25 mg Tablets in Healthy Subjects Under Non-Fasting Conditions: Complete Statistical AnalysisIndependent statistical analysis of Losartan Potassium/Hydrochlorothiazide 100/25 mg Tablets in Healthy Subjects Under Non-Fasting Conditions: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- LOSSIndependent statistical analysis of LOSS- Louisiana Obese Subjects Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00115063).
- Loteprednol Etabonate Ophthalmic Ointment vs. Vehicle in the Treatment of Inflammation Following Cataract Surgery: Complete Statistical AnalysisIndependent statistical analysis of Loteprednol Etabonate Ophthalmic Ointment vs. Vehicle in the Treatment of Inflammation Following Cataract Surgery: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- LOTUSIndependent statistical analysis of Exploratory Study of the Effects of Omega-3-acid Ethyl Esters on the Lipid and Lipoprotein Profile in the Blood: primary endpoint results, effect estimate with confidence interval, sample-size planning…
- LOTUSDIIndependent statistical analysis of A Study of 0.03% Bimatoprost in the Treatment of Primary Open Angle Glaucoma and Ocular Hypertension: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- LOUiSSeIndependent statistical analysis of A Phase 2 Study to Evaluate the Safety and Efficacy of LOU064 in Patients With Moderate to Severe Sjögren's Syndrome: primary endpoint results, effect estimate with confidence interval,…
- Lovastatin in Treating Patients At High Risk of Melanoma: Complete Statistical AnalysisIndependent statistical analysis of Lovastatin in Treating Patients At High Risk of Melanoma: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00462280).
- LOVIT IIIndependent statistical analysis of Low Vision Intervention Trial II (LOVIT II): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00958360).
- Low Dose Arsenic Trioxide as a Potential Chemotherapy Protector: Complete Statistical AnalysisIndependent statistical analysis of Low Dose Arsenic Trioxide as a Potential Chemotherapy Protector: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01428128).
- Low Dose Parenteral Fat for Prevention of Parenteral Nutrition Associated Cholestasis in Preterm Neonates: Complete Statistical AnalysisIndependent statistical analysis of Low Dose Parenteral Fat for Prevention of Parenteral Nutrition Associated Cholestasis in Preterm Neonates: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- Low Nicotine Cigarettes Plus Electronic Cigarettes: Complete Statistical AnalysisIndependent statistical analysis of Low Nicotine Cigarettes Plus Electronic Cigarettes: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04058717).
- Low-dose IL-2( Interleukin-2) Treatment in SLE: Complete Statistical AnalysisIndependent statistical analysis of Low-dose IL-2( Interleukin-2) Treatment in SLE: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02084238).
- Low-Dose Naltrexone (LDN) for Depression Relapse and Recurrence: Complete Statistical AnalysisIndependent statistical analysis of Low-Dose Naltrexone (LDN) for Depression Relapse and Recurrence: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01874951).
- Low-Dose Prednisone or Methylprednisolone in Treating Patients With Newly Diagnosed Acute Graft-versus-Host Disease: Complete Statistical AnalysisIndependent statistical analysis of Low-Dose Prednisone or Methylprednisolone in Treating Patients With Newly Diagnosed Acute Graft-versus-Host Disease: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Low-Dose Versus High-Dose Oxytocin Dosing for Induction and Augmentation of Labor: Complete Statistical AnalysisIndependent statistical analysis of Low-Dose Versus High-Dose Oxytocin Dosing for Induction and Augmentation of Labor: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- LOWR-4Independent statistical analysis of Titrating-Dose of Lonafarnib in Combination With Ritonavir: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02527707).
- Lubiprostone (Amitiza®) Vs. Standard Care in Opioid-induced Constipation After Surgery in Inpatient Rehabilitation: Complete Statistical AnalysisIndependent statistical analysis of Lubiprostone (Amitiza®) Vs. Standard Care in Opioid-induced Constipation After Surgery in Inpatient Rehabilitation: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Lumbar Plexus vs Quadratus Lumborum Block in Post-operative Pain Following Total Hip Replacement: Complete Statistical AnalysisIndependent statistical analysis of Lumbar Plexus vs Quadratus Lumborum Block in Post-operative Pain Following Total Hip Replacement: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Lung Cancer Screening Eligibility Assessment: Complete Statistical AnalysisIndependent statistical analysis of Lung Cancer Screening Eligibility Assessment: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT06133816).
- Lung-MAP: Palbociclib as Second-Line Therapy in Treating Cell Cycle Gene Alteration Positive Patients With Recurrent Stage IV Squamous Cell Lung Cancer: Complete Statistical AnalysisIndependent statistical analysis of Lung-MAP: Palbociclib as Second-Line Therapy in Treating Cell Cycle Gene Alteration Positive Patients With Recurrent Stage IV Squamous Cell Lung Cancer: primary endpoint results, effect estimate with confidence…
- LUX-Lung 6Independent statistical analysis of LUX-Lung 6, the randomized phase 3 trial comparing afatinib with gemcitabine-cisplatin chemotherapy in first-line non-small cell lung cancer. Includes progression-free survival, response, overall survival, quality-of-life endpoints, statistical methods,…
- LUX-Lung 7Independent statistical analysis of LUX-Lung 7, the randomized phase 2 trial comparing afatinib with gefitinib in first-line EGFR mutation-positive lung adenocarcinoma, including survival, response, quality-of-life, and safety analyses.
- LY3819253 (LY-CoV555) for Inpatients With COVID-19 (An ACTIV-3/TICO Treatment Trial): Complete Statistical AnalysisIndependent statistical analysis of LY3819253 (LY-CoV555) for Inpatients With COVID-19 (An ACTIV-3/TICO Treatment Trial): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT05780268).
- Lyophilized IMVAMUNE® (1×10^8 TCID50) Versus Liquid IMVAMUNE® (1×10^8 TCID50) Administered Subcutaneously and a Lower Dose Liquid IMVAMUNE® (2×10^7 TCID50) Administered Intradermally: Complete Statistical AnalysisIndependent statistical analysis of Lyophilized IMVAMUNE® (1x10^8 TCID50) Versus Liquid IMVAMUNE® (1x10^8 TCID50) Administered Subcutaneously and a Lower Dose Liquid IMVAMUNE® (2x10^7 TCID50) Administered Intradermally: primary endpoint results, effect estimate with confidence…
- M-F0434Independent statistical analysis of Neuropathic Pain Management: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01263132).
- M-MILKIndependent statistical analysis of Multisensory Early Oral Administration of Human Milk in Preterm Infants: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT06230848).
- M2-ABMGIndependent statistical analysis of A Study to Evaluate the Safety and Immunogenicity of Oral Polio Vaccine Type 2 in Infants and Children: primary endpoint results, effect estimate with confidence interval, sample-size planning…
- MA181Independent statistical analysis of Assessing Choice in the Employer Setting (ACES) Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00808808).
- Macrophage Phagocytosis in COPD: Complete Statistical AnalysisIndependent statistical analysis of Macrophage Phagocytosis in COPD: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00298389).
- MADIndependent statistical analysis of Mandibular Advancement Device and Changes in Nocturia: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT05562388).
- MAGELLANIndependent statistical analysis of Melatonin Agonist Effects of Tasimelteon Versus Placebo in Patients With Major Depressive Disorder: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- MAGELLAN-3Independent statistical analysis of Efficacy and Safety of Glecaprevir (ABT-493)/Pibrentasvir (ABT 530) (GLE/PIB) in Combination With Sofosbuvir and Ribavirin in Participants With Hepatitis C Virus Who Did Not Respond to Treatment in…
- Magnesium Supplementation for the Prevention of Supraventricular Arrhythmias: Complete Statistical AnalysisIndependent statistical analysis of Magnesium Supplementation for the Prevention of Supraventricular Arrhythmias: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02837328).
- Magnesium vs Placebo for Tonsillectomy: Complete Statistical AnalysisIndependent statistical analysis of Magnesium vs Placebo for Tonsillectomy: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02218424).
- Magnetic Resonance Imaging Study of Lisdexamfetamine for Bipolar Depression: Complete Statistical AnalysisIndependent statistical analysis of Magnetic Resonance Imaging Study of Lisdexamfetamine for Bipolar Depression: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01051440).
- Magnetic Resonance Spectroscopy Study of Memantine in Alzheimer’s Disease: Complete Statistical AnalysisIndependent statistical analysis of Magnetic Resonance Spectroscopy Study of Memantine in Alzheimer's Disease: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00551161).
- MAGNIFYIndependent statistical analysis of Lenalidomide Plus Rituximab Followed by Lenalidomide Versus Rituximab Maintenance for Relapsed/Refractory Follicular, Marginal Zone or Mantle Cell Lymphoma.: primary endpoint results, effect estimate with confidence interval, sample-size planning…
- MAHALEIndependent statistical analysis of Efficacy and Safety of Benralizumab in Patients With Non-cystic Fibrosis Bronchiectasis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- MAINIndependent statistical analysis of Memory and Insulin in Early Alzheimer's Disease: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00581867).
- MAINTAIN-PCIndependent statistical analysis of Computer-Based Weight Maintenance in Primary Care: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01946191).
- Maintaining Nonsmoking: Older Smokers – 1: Complete Statistical AnalysisIndependent statistical analysis of Maintaining Nonsmoking: Older Smokers - 1: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00086385).
- Making Better Lives: Patient-Focused Care for Low Back Pain (LBP): Complete Statistical AnalysisIndependent statistical analysis of Making Better Lives: Patient-Focused Care for Low Back Pain (LBP): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02697435).
- Malignant Pleural Effusion With ZD6474: Complete Statistical AnalysisIndependent statistical analysis of Malignant Pleural Effusion With ZD6474: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00402896).
- MALMSIndependent statistical analysis of Metformin to Augment Low Milk Supply (MALMS) Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02179788).
- MamaMoveIndependent statistical analysis of A Home Exercise Program for Women With Infants & Young Children: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Management of Chronic Pain and PTSD in Gulf War Veterans With tDCS+Prolonged Exposure: Complete Statistical AnalysisIndependent statistical analysis of Management of Chronic Pain and PTSD in Gulf War Veterans With tDCS+Prolonged Exposure: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Management of Etonogestrel Subdermal Implant-related Bleeding: Complete Statistical AnalysisIndependent statistical analysis of Management of Etonogestrel Subdermal Implant-related Bleeding: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01658995).
- Management of Platelet Transfusion Therapy in Patients With Blood Cancer or Treatment-Induced Thrombocytopenia: Complete Statistical AnalysisIndependent statistical analysis of Management of Platelet Transfusion Therapy in Patients With Blood Cancer or Treatment-Induced Thrombocytopenia: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…